Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Seroquel in Agitation Associated With Dementia
NCT00621647Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Sep 2002
- Primary completion
- Nov 2003
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of quetiapine in Dementia (3 arms), sponsored by AstraZeneca. Primary endpoint: Efficacy of Quetiapine compared with Placebo. Started Sep 2002; status: completed.
02
Drugs
quetiapine
03
Conditions
Dementia
Beyond the preview
Go deeper on NCT00621647.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00621647.